West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
West Pharmaceutical Services, Inc.
470 W. Vaughn Dr., Tempe, AZ 85283-3671
CategoryMedical Instruments & Supplies
As a company that is by the side of our customers, team members, the patients we serve and the communities in which we live and work, we are also driven to be by the side of our planet. Caring for our environment is inherent in all we do, ensuring that we use resources in a sustainable manner and believing that we have an obligation to contribute to a healthier world. For the past 100 years, West has been committed to working side-by-side with our customers to improve patient health. We are also committed to helping to create a healthier environment and to being good stewards of a sustainable future.At West, our commitment to quality is anchored in our Core Value of Leadership in Quality. This value is a constant reminder that we must never compromise on quality because we know that millions of patients are relying on our products every day. This focus on quality includes excellence in manufacturing and design, as well as in quality management systems. We know that a strong Quality Management System (QMS) and global harmonization of processes create the foundation needed to support an enterprise-wide Quality Culture. Built upon this foundation is our Quality Strategy, which focuses on ensuring that finished products are of the highest quality with an emphasis on patient safety; building a diverse, competency-based quality organization; achieving reductions in the overall cost of quality; supporting business growth through the deployment of best-in-class quality processes and procedures to ensure scalability for future growth; and importantly,driving improved customer satisfaction through timely investigations of and responses to complaints.In 2022, the Quality leadership team was expanded to best support our Quality Strategy. This expansion included the addition of new roles focused on: Supplier Quality — ensuring end-to-end supplier quality management; Quality Systems — focusing on the harmonization of West’s QMS; and Quality Excellence — focusing on product quality, continuous improvement, reducing waste, and lean six sigma. A key area of focus throughout the year was to ensure that we foster a stronger Quality Culture across the global organization. We know that a strong Quality Culture creates an environment where all team members share a set of values, beliefs, and behaviors that are committed to quality.In 2018, West conducted our first materiality assessment to gain insight into which ESG topics were the most top-of-mind for our stakeholders. Through a survey of relevant internal stakeholders and customers, we were able to analyze the issues most relevant to our business growth and customers’ goals. To achieve this, we asked respondents when taking the survey to assign value with relevance to the company in mind, as opposed to which were the greatest issues facing the world. In 2020, we repeated this process to assess how the ESG landscape had shifted in the past few years. The 2020 materiality assessment results showed that both internal and external stakeholders remained mostly in agreement with the overall importance of the listed material issues to West’s operations.The Business Compliance & Integrity program is designed to prevent and detect misconduct and help the Company abide by the letter and spirit of the laws in all the countries in which West operates. We require our employees to complete annual training on West’s Code of Conduct and other corporate policies on ethical business practices and have systems in place designed to detect violations of laws, regulations and company policies. The Business Compliance & Integrity Department is dedicated to empowering employees to make better decisions and drive growth by doing the right things in the right way every day. This means each West team member knows, understands and acts in the best of interest of West which includes the patients who use our products, our customers and their fellow West team members across the globe. This requires each of us to act with integrity, honesty and transparency everyday. All West team members must uphold these values and principles to help ensure that West continues as a well-respected, ethical and lawful leader in the healthcare industry.